Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Revascularization with drug-coated balloons alone in complex coronary artery disease: a systematic review.

Clinical research in cardiology : official journal of the German Cardiac Society·2026

Same author

Impact of Strut Thickness for Patients Treated With Percutaneous Revascularization for Coronary Bifurcations: Insights From the BIFURCAT-ULTRA Registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Same author

Paclitaxel Noninferior to Paclitaxel: Registry-Scale Evidence for an Urea-Excipient Drug-Coated Balloon in a Real World Population: A Commentary on the SCAAR Nationwide Comparative Registry Analysis.

Journal of the American Heart Association·2026

Same author

Intravascular Imaging-Guided Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Stenosis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Same author

Primary Results of the SALAMANDER Registry: A Multicenter Observational Cohort Study.

Journal of the American Heart Association·2026

Same author

Mechanism- and Physiology-Guided Drug-Coated Balloon-Only Percutaneous Coronary Intervention in Complex Multivessel Coronary Artery Disease: Insights From IVUS and vFFR.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Thrombectomy for thrombus removal, filters for whatever else.

Ugo Limbruno¹, Bernardo Cortese, Silva Severi

¹Interventional Cardiology, Misericordia Hospital, Grosseto, Italy.

Journal of Cardiovascular Medicine (Hagerstown, Md.)

|March 13, 2008

Summary

Current thrombectomy devices reduce embolic burden but may release plaque components. These components can contribute to no-reflow during percutaneous coronary intervention, impacting treatment effectiveness.

More Related Videos

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Area of Science:

Cardiovascular medicine
Interventional cardiology
Biomedical engineering

Background:

Percutaneous coronary intervention (PCI) is a common procedure for treating coronary artery disease.
Thrombectomy devices are used to remove blood clots during PCI.
The no-reflow phenomenon remains a challenge in primary PCI, potentially leading to adverse outcomes.

Observation:

Existing thrombectomy devices effectively reduce the overall embolic load.
However, these devices may inadvertently liberate atheroma or plaque components.
These liberated components are implicated as a potential cause of the no-reflow phenomenon.

Findings:

Thrombectomy may not fully prevent the shedding of plaque material into the coronary vasculature.
The release of plaque components during thrombectomy is a significant concern.
This liberation can negatively impact microvascular function post-intervention.

Implications:

Novel thrombectomy strategies are needed to mitigate plaque component liberation.
Preventing no-reflow could improve PCI outcomes and patient recovery.
Further research into device design and embolic protection is warranted.